Amarin Corporation Probability Of Bankruptcy

  

Probability Of Bankruptcy Analysis

For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis.The score is used to predict probability of a firm or a fund going into bankruptcy or experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Amarin Corporation 
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
 = 
84 %

Distress Driver Correlations

About Probability Of Bankruptcy

Companies or funds with Probability Of Bankruptcy above 90% are generally considered to be high risk with a good chance of bankruptcy in the next 2 years. On the other hand entities with Probability Of Bankruptcy of less than 15% will most likely experience some growth in the next 2 years. Probability Of Bankruptcy is based on Macroaxis own algorithm and can be used by auditors, accountants, money managers, financial advisers, as well as day traders to evaluate unsystematic risk of a stock, fund or ETF.
Compare Amarin Corporation to competition

Amarin Corporation Probability Of Bankruptcy Assessment

  Of Bankruptcy 
Benchmark  Embed   Amarin Corporation Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 84%. This is 84.82% higher than that of the Healthcare sector, and 33.67% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 131.21% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Probability Of Bankruptcy

Probability Of Bankruptcy Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Found 10 equities by Probability Of Bankruptcy
NVO NYQNovo Nordisk AS
1 %
TEVA NYQTeva Pharmaceutical Industries Limited
35 %
RDY NYQDr Reddys Laboratories Ltd
2 %
TARO NYQTaro Pharmaceutical Industries Ltd
1 %
UTHR NMSUnited Therapeutics Corporation
1 %
ENDP NMSEndo International plc
51 %
DEPO NMSDepoMed Inc
47 %
SCLN NMSSciClone Pharmaceuticals Inc
2 %
AMPH NMSAmphastar Pharmaceuticals Inc
1 %
SCMP NGMSucampo Pharmaceuticals Inc
46 %
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  

Chance of Financial Distress

Amarin Corporation plc has more than 84 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Return On Asset(32.02) %
Profit Margin(124.61) %
Operating Margin(103.19) %
Current Valuation540.19 M
Shares Outstanding184.44 M
Shares Owned by Insiders10.16 %
Shares Owned by Institutions29.30 %
Number of Shares Shorted15.97 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales4.28 times
Revenue91.37 M
Gross Profit53.88 M
EBITDA(93.46 M)
Net Income(146.84 M)
Cash and Equivalents81.36 M
Cash per Share0.44 times
Total Debt243.45 M
Current Ratio2.32 times
Book Value Per Share(0.98) times
Cash Flow from Operations(96.92 M)
Short Ratio16.58 times
One Year High2.65
One Year Low1.24
Earnings Per Share(0.81) times
Price to Earnings To Growth(0.02) times
Number of Employees210
Beta0.6
Market Capitalization378.1 M
Total Asset152.71 M
Retained Earnings(1.15 B)
Working Capital70.84 M
Current Asset124.43 M
Current Liabilities53.59 M
Z Score-9.2